Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
June 16, 2017 13:06 ET
|
Genmab A/S
Company Announcement
DARZALEX (daratumumab) approved by U.S. FDA in combination with pomalidomide and dexamethasone for patients with multiple myeloma who have received at least two prior...
Genmab Announces Preliminary Cervical Cancer Data from Tisotumab Vedotin Phase I/II Study
June 16, 2017 10:29 ET
|
Genmab A/S
Company Announcement
Preliminary data shows responses achieved in 11 of 34 evaluable patients with cervical cancer treated with tisotumab vedotin
Next steps in clinical development of...
Selskabsvedtægter for Genmab A/S
June 15, 2017 08:52 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 8. juni 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Articles of Association for Genmab A/S
June 15, 2017 08:52 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated June 8, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Grant of Restricted Stock Units and Warrants to Genmab employees
June 08, 2017 13:46 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; June 8, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 1,697 restricted stock units and...
Genmab to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
May 30, 2017 08:40 ET
|
Genmab A/S
Media Release
Copenhagen, Denmark; May 30, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the Goldman Sachs...
Selskabsvedtægter for Genmab A/S
May 17, 2017 14:26 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 16. maj 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Articles of Association for Genmab A/S
May 17, 2017 14:26 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated May 16, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel Curtis...
Genmab Announces Plans for New Studies of Daratumumab
May 17, 2017 13:18 ET
|
Genmab A/S
Company Announcement
3 new Phase III studies of daratumumab planned in multiple myeloma and amyloidosis
Studies planned to start between second half 2017 and first quarter...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
May 16, 2017 11:16 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; May 16, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 43,252 shares as a consequence of the exercise of employee...